The UK-US zero-tariff pharma deal removes US duties on British medicines while requiring major NHS pricing reforms, higher spending on innovative drugs and new NICE evaluation thresholds.
Rubio calls US-Ukraine talks productive but more work needed after Florida negotiations on a revised US peace plan, as Washington and Kyiv adjust proposals on elections
WTDC25 in Baku spotlights digital inclusion and global cooperation, focusing on affordable connectivity, cybersecurity, funding models and sustainable digital development.
Owens claims the Macrons ordered her assassination but provides no evidence, sparking legal, political, and media backlash as the defamation case escalates.
Ukraine peace talks for Europeans now centre on NATO access, sanctions leverage and frozen Russian assets, as EU leaders fight to protect their strategic influence
Bayer surges and Novo Nordisk sinks 10% in a major pharma market shake-up, driven by trial breakthroughs, obesity-drug volatility, and shifting investor sentiment. Full analysis inside.
The U.S. says steel tariff cuts will only happen if the EU softens digital-rules enforcement, tying trade relief to changes in tech regulation. A detailed look at the geopolitical and economic implications.
US and Ukrainian delegations report progress on ending Russian invasion after talks in Geneva, with updated security guarantees,
The EU funding stance on Palestinian Authority reaffirms political support but provides no new money, linking future aid to governance reforms and verified financial accountability.
Dutch government suspends takeover of Chinese-owned Nexperia after diplomatic progress with China, as Europe confronts chip-security risks and supply-chain instability.
© THE CEO PUBLICATION 2021 | All rights reserved. Terms and condition | Privacy and Policy
